Febit, a provider of life sciences research products and services, has cut 60 percent of its work force at its headquarters in Heidelberg, Germany, and U.S. office in Lexington, MA, according to a press release. The cuts come as result of the company’s shift away from DNA sequencing services and increased focus on providing tests that find microRNA biomarkers in blood for such uses as drug research and diagnostics development. The company has reduced its staff from 90-100 workers to 30 employees worldwide, said company spokeswoman Martina Schwarzkopf. She said most of the cuts were made in Germany, where the firm has the majority of its staff.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
